Pharmacokinetics of the new potential antiparkinsonian agent ADK-1113 after different dosage regimens in mice

The pharmacokinetics of ADK-1113 were studied in mice treated with different dosage regimens.Objective. This study aimed to investigate ADK-1113 pharmacokinetics after multiple intraperitoneal administrations.Methods. This study was conducted on male outbred mice. The concentrations of ADK-1113 in t...

ver descrição completa

Detalhes bibliográficos

Principais autores:	D. A. Dvoryaninov, O. Yu. Kravtsova, O. G. Gribakina, G. B. Kolyvanov, A. A. Litvin, V. P. Zherdev, V. L. Dorofeev
Formato:	Artigo
Idioma:	Russo
Publicado em:	LLC “Publisher OKI” 2025-08-01
Colecção:	Фармакокинетика и Фармакодинамика
Assuntos:	фармакокинетика антипаркинсоническое средство адк-1113 мыши многократное введение кумуляция
Acesso em linha:	https://www.pharmacokinetica.ru/jour/article/view/459
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!